Spink B C, Katz B H, Hussain M M, Pang S, Connor S P, Aldous K M, Gierthy J F, Spink D C
Wadsworth Center, New York State Department of Health, Albany, NY 12201-0509, USA.
Carcinogenesis. 2000 Nov;21(11):1947-57. doi: 10.1093/carcin/21.11.1947.
In a previous study of nine human breast-derived cell lines, rates of metabolism of 17beta-estradiol (E(2)) were greatly enhanced when cultures were exposed to the aromatic hydrocarbon receptor agonist, 2,3,7,8-tetrachlorodibenzo-p-dioxin. Elevated rates of E(2) hydroxylation at the C-2, -4, -6alpha and -15alpha positions were observed concomitant with the induction of cytochromes P450 1A1 and 1B1. In each cell line, 2- and 4-hydroxyestradiol (2- and 4-OHE(2)) were converted to 2- and 4-methoxyestradiol (2- and 4-MeOE(2)) by the action of catechol O:-methyltransferase. In this study, conjugation of these estrogen metabolites was investigated. A comparison of the levels of metabolites determined with and without prior treatment of the media with a crude beta-glucuronidase/sulfatase preparation showed that most of the 2-MeOE(2) present was in conjugated form, whereas 4-MeOE(2), 6alpha-OHE(2) and 15alpha-OHE(2) were minimally conjugated. Inhibitor studies suggested that it was the sulfatase activity of the preparation that hydrolyzed the 2-MeOE(2) conjugates in MCF-7 cell media; the presence of 2-MeOE(2)-3-sulfate in MCF-7 culture media was confirmed by electrospray ion-trap mass spectrometry. To identify the enzyme catalyzing this conjugation, the expression of mRNAs encoding five sulfotransferases (SULT1A1, SULT1A2, SULT1A3, SULT1E1 and SULT2A1) was evaluated in the nine cell lines by use of the reverse transcription-polymerase chain reaction. Only expression of SULT1A1 mRNA correlated with the observed conjugation of nanomolar levels of 2-MeOE(2) in these cell lines. Cloning and sequencing of SULT1A1 cDNA from MCF-7 cells revealed that mRNAs encoding two previously identified allelic variants, SULT1A11 ((213)Arg) and SULT1A12 ((213)His), were expressed in these cells. Heterologous cDNA-directed expression of either variant in MDA-MB-231 cells, which do not normally express SULT1A1, conferred 2-MeOE(2) sulfonation activity. The SULT1A1 allelic variants were also expressed in SF:9 insect cells, from which post-microsomal supernatants were used to determine K:(m) values of 0.90 +/- 0.12 and 0.81 +/- 0.06 microM for SULT1A11 and SULT1A12, respectively, with 2-MeOE(2) as substrate. These results show that SULT1A1 is an efficient and selective catalyst of 2-MeOE(2) sulfonation and, as such, may be important in modulating the anticarcinogenic effects of 2-MeOE(2) that have been described recently.
在先前一项对九种人源乳腺细胞系的研究中,当培养物暴露于芳烃受体激动剂2,3,7,8 - 四氯二苯并 - p - 二恶英时,17β - 雌二醇(E₂)的代谢速率大幅提高。在细胞色素P450 1A1和1B1诱导的同时,观察到E₂在C - 2、- 4、- 6α和- 15α位的羟基化速率升高。在每个细胞系中,2 - 和4 - 羟基雌二醇(2 - 和4 - OHE₂)通过儿茶酚 - O - 甲基转移酶的作用转化为2 - 和4 - 甲氧基雌二醇(2 - 和4 - MeOE₂)。在本研究中,对这些雌激素代谢物的结合进行了研究。用粗制β - 葡萄糖醛酸酶/硫酸酯酶制剂处理培养基前后所测定的代谢物水平比较表明,所存在的大部分2 - MeOE₂呈结合形式,而4 - MeOE₂、6α - OHE₂和15α - OHE₂的结合程度最低。抑制剂研究表明,是该制剂的硫酸酯酶活性水解了MCF - 7细胞培养基中的2 - MeOE₂结合物;通过电喷雾离子阱质谱法证实了MCF - 7培养基中存在2 - MeOE₂ - 3 - 硫酸盐。为了鉴定催化这种结合的酶,通过逆转录 - 聚合酶链反应在九种细胞系中评估了编码五种磺基转移酶(SULT1A1、SULT1A2、SULT1A3、SULT1E1和SULT2A1)的mRNA的表达。在这些细胞系中,只有SULT1A1 mRNA的表达与所观察到的纳摩尔水平的2 - MeOE₂的结合相关。从MCF - 7细胞克隆和测序SULT1A1 cDNA表明,编码两种先前鉴定的等位基因变体SULT1A11((213)Arg)和SULT1A12((213)His)的mRNA在这些细胞中表达。在通常不表达SULT1A1的MDA - MB - 231细胞中,这两种变体的异源cDNA定向表达赋予了2 - MeOE₂磺化活性。SULT1A1等位基因变体也在SF:9昆虫细胞中表达,利用来自该细胞的微粒体后上清液以2 - MeOE₂为底物测定SULT1A11和SULT1A12的米氏常数(Kₘ)值分别为0.90±0.12和0.81±0.06μM。这些结果表明,SULT1A1是2 - MeOE₂磺化的高效且选择性催化剂,因此可能在调节最近所描述的2 - MeOE₂的抗癌作用中起重要作用。